299. Cystic fibrosis Clinical trials / Disease details

Clinical trials : 1,696 / Drugs : 1,644 - (DrugBank : 272) / Drug target genes : 96 - Drug target pathways : 170

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04732195 (ClinicalTrials.gov)	January 20, 2022	25/1/2021	Pilocarpine Microneedles for Sweat Induction (PMN-SI)	A Pilot Study to Compare the Efficacy of Pilocarpine Microneedles With Iontophoresis Method for Sweat Induction in Healthy Human Subjects	Cystic Fibrosis	Device: Pilocarpine microneedle patch;Device: Pilocarpine Iontophoresis	Emory University	Georgia Institute of Technology	Recruiting	18 Years	N/A	All	50	N/A	United States
2	NCT03584841 (ClinicalTrials.gov)	March 31, 2017	27/5/2018	Implementation of a Non-invasive Version of the Imaging ß-adrenergic-dependent Sweat Secretion Test	Implementation of a Non-invasive Version of the Imaging ß-adrenergic-dependent Sweat Secretion Test: Value for Diagnosis and Efficacy of Target Therapies for Cystic Fibrosis	Mucoviscidosis Involving the Lung	Diagnostic Test: Iontophoresis sessions in forearm of subjects with pilocarpine	Cliniques universitaires Saint-Luc- Université Catholique de Louvain	NULL	Recruiting	18 Years	100 Years	All	120	N/A	Belgium
3	NCT02310789 (ClinicalTrials.gov)	July 31, 2015	3/9/2014	(Study: Vertex IIS) Does Ivacaftor Alter Wild Type CFTR-Open Probability In The Sweat Gland Secretory Coil?	(Study: Vertex IIS) A Study To Access the Effects of Ivacaftor on Wild Type CFTR-Open Probability (PO) In The Sweat Gland Secretory Coil	Cystic Fibrosis	Drug: Ivacaftor;Drug: ß-Adrenergic cocktail;Drug: Pilocarpine Nitrate 5%;Device: Macroduct sweat stimulator	Richard Barry Moss	NULL	Completed	18 Years	N/A	All	8	N/A	United States